Skip to content

Bausch Health Companies BHC Book value per share

Book value per share at other companies

PBH
Prestige Consumer HealthcarePBH
$38.74+5.7%
Bausch + Lomb logo
Bausch + LombBLCO
$17.96-0.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$33.20+3.0%
AbbVie logo
AbbVieABBV
-$3.75-568%
Organon logo
OrganonOGN
$3.43+65.4%
HRO
HarrowHROW
$0.77-51.1%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Calculated from Bausch Health Companies’s reported figures.

Based on the most recent quarter.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's book value per share?
Bausch Health Companies (BHC) reported book value per share of -$5.52 in Q1 2026.
How has Bausch Health Companies's book value per share changed year-over-year?
Bausch Health Companies's book value per share decreased by 72.6% year-over-year, from -$3.20 to -$5.52.
What is the long-term trend for Bausch Health Companies's book value per share?
Over 5 years (2020 to 2025), Bausch Health Companies's book value per share has grown at a -0.4% compound annual growth rate (CAGR), from $1.51 to -$1.48.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.